6-Azathymidine, 6-aza-2'-deoxycytldlne, 6-methy1-2'-deoxyuridine, and 5,6-dimethy1-2'-deoxyuridlne nucleosldes have been converted to phosphoramldite synthons and Incorporated Into oligodeoxynucleotides (ODNs). ODNs containing from 1 to 5 of these modified pyrimidines were compared with known 2'-deoxyurldlne, 5-iodo-2'-deoxyurldlne, 5-bromo-2'-deoxyurldlne, 5-fluoro-2'-deoxyuridine, 5-bromo-2'-deoxycytidine, and 5-methyl-2'-deoxycytidlne nucleoslde modifications. Stability In 10% heat Inactivated fetal calf serum, binding affinities to RNA and DNA complements, and ability to support RNase H degradation of targeted RNA In DNA-RNA heteroduplexes were measured to determine structure-activity relationships. 6-Azathymldlne capped ODNs show an enhanced stability in serum (7-to 12-fold Increase over unmodified ODN) while maintaining hybridization properties similar to the unmodified ODNs. A 22-mer ODN having Its eight thymine bases replaced by eight 6-azathymines or 5-bromouracils hybridized to a target RNA and did not Inhibit RNase H mediated degradation.
INTRODUCTION
A variety of modified and unmodified oligonucleotides (ODNs) have been examined as antisense inhibitors of gene expression (1). Although progress has been made in this drug discovery approach, certain pharmacokinetic factors may limit the use of unmodified antisense ODNs in vivo (2) . In particular, degradation by ubiquitous nucleases will most likely render unmodified ODNs unsuitable as antisense drugs. Approaches to overcome this problem have primarily been directed towards modifications at the phosphorus atom of the phosphodiester linkage, for example, phosphorothioates, methylphosphonates, and phosphoramidates (3) . Though significant resistance to nuclease degradation results from phosphorus modifications, other antisense properties such as binding affinity and the ability to support RNase H mediated degradation of the RNA are compromised (4) . Interestingly, modification of the heterocyclic bases in ODNs to obtain nuclease resistance has received very little attention (5) . The lack of significant work in the heterocycle part of ODNs most likely reflects the thought that this type of modification will preclude Watson-Crick base-pair hydrogen bonding essential for the formation of stable heteroduplexes.
In an effort to modulate antisense ODNs properties, we studied the nuclease sensitivity and hybridization properties of ODNs containing pyrimidines modified at their 5-and/or 6-positions. Modifications at these positions lie in the major groove and should not directly affect the pyrimidine hydrogen bonding. However, the same modification might alter the syn/anti -conformation about the glycosyl bond (x), particularly with a bulky peripheral modification in the 6-position, and could indirectly affect Watson-Crick base pairing at a specific position.
We postulate that the 6-position of the pyrimidine ring of cytosine and thymine may serve as a binding site for certain nucleases (6) . If the 6-position of pyrimidines is required for nuclease binding, then removal of one or more or these electropositive centers in antisense ODNs may provide nuclease resistance. Placement of a ring-nitrogen in the 6-position of cytosine and thymine (for example: 6-azapyrimidines) might reverse the electronic effect by providing an electronegative center, thus, preventing putative nuclease binding. A 6-azapyrimidine modification would also have the advantage of not providing steric bulk which may interfere with the glycosyl bond conformation. Placing a substituent at the 6-positions of cytosine bases and thymine bases within oligonucleotides may also interfere with nuclease recognition of the oligonucleotide. However, hybridization properties may be compromised due to the perturbation of the .yyn/artri-conformation.
Sugar-modified ODNs such as 2'-O-methyl (7), 2'-deoxy-2'-fluoro (8), a-ODNs (9) and carbocyclic ODNs (10) failed to support RNase H mediated degradation in RNA-DNA duplexes. Terminating essential RNA processing by this mode of action may be an important event in the activity of antisense ODNs (11) and points to the design of modified ODNs which form heteroduplexes that support RNase H activity. We suggest that heterocyclic modification of ODNs as described in this paper, may only have minimal effects on heteroduplex structure and thus, support RNase H degradation of targeted RNA.
Herein, we describe the synthesis of several pyrimidine nucleosides phosphoroamidite synthons and their incorporation into an antisense ODN sequence by automated DNA synthesis. Structure-activity relationships (SAR) were determined by replacing one or more thymine/cytosine bases in 16-mer ODN sequence with modified pyrimidines. Modified ODNs were examined for their nuclease stability in 10% fetal calf serum (FCS), binding affinity to DNA and RNA complements, and the ability of these modified ODN to support RNase H mediated cleavage.
RESULTS

Synthesis of modified blocked nucleosides
Our route to the synthesis of 6-azathymidine (6), 6-aza-2'-deoxycytidine (10), 6-methyl-2'-deoxyuridine (15) and 5,6-dimethyl-2'-deoxyuridine (20) is illustrated in Scheme 1. The blocked nucleosides 23-28 were commercially available (12). The recently described procedure for the synthesis of 2'-deoxynucleosides via Cul catalyst (13) quantities of nucleosides 6, 10 and 20. Thus, glycosylation of silylated 6-azauracil (1) with l-chloro-2-deoxy-3,5-di-0-/>-toluoyl-a-D-e-ryf/iropentofuranose (3) (14) furnished blocked nucleoside 4 in 70% yield as the major isolated product after chromatography. The blocked nucleoside 4 was further converted into 6-aza-2'-deoxycytidine (10) by a reported procedure (15) . The latter compound 10 on dimethoxytritylation gave 11 (91 %), which on selective N-benzoylation furnished 12 (67%). Phosphitylation of 12 yielded the desired protected 13 (79%) as a glassy material. 'H and 31 P NMR of compound 13 (Table 1 ) indicated the desired structure of high purity. Following the general glycosylation procedure, silylated 2 was coupled with 3 to furnish 5 in 75 % isolated yield. The latter compound 5 was conveniently deblocked by NaOMe/MeOH to furnish 6 in quantitative yield. 6-Azathymidine (6) on dimethoxytritylation followed by phosphitylation gave 8 as white foam in 66% overall yield. The structure of compound 8 was established by 'H and 31 P NMR data qable 1).
Deoxyribosylation of silylated 18 in the presence of Cul furnished two products in a 7:3 ratio; purification by silica gel chromatography afforded 19 (50%) as crystalline product. The minor product was characterized as N-3 positional isomer of 19. Tables 2 and 3 were synthesized by standard solid-support phosphoramidite chemistries on an automated DNA synthesizer (17) . We chose a 16-mer sequence [5'-d (TCCAGGTGTCGGCATQ] from the 5-lipoxygenase 5'-untranslated region having a reasonable representation of pyrimidine bases and lacking discernible hairpin structures as one target molecule. Modified ODNs were synthesized by coupling the desired modified amidite (8,13,17, 22-28) at the preselected positions. The effectiveness of the coupling was considerably improved by introducing a longer wait step (-6 min) during the synthesis. The stepwise coupling efficiency was calculated by measuring released DMT cation for each synthesis (1 /xmol) and found to be greater than 98%. The ODNs were removed from the CPG-support by standard NH4OH treatment and purified on a reverse phase HPLC column as the 5'-DMT species. Detritylation of each ODNs was carried out under standard conditions to furnish ODNs. The purity of the final detritylated ODNs products was determined by means of denaturing polyacrylamide gel electrophoresis and were found to be greater than 90% full length ODN. 6-Aza T linked to the CPG support, prepared via standard methods (18) , was utilized to incorporate the modified oligonucleotide at the 3'-terminal end of ODNs for nuclease stability studies.
The integrity and stability of sequences containing 6-aza T residues was demonstrated by examining the relative nucleoside ratios of a 22-mer 5'-AAA TAG TGT TGC TGA TCT TGA C, wherein T represents the incorporation of 6-aza T. This molecule was enzymatically degraded, and nucleotides dephosphorylated to the corresponding nucleosides and analyzed by HPLC. The calculated relative ratios of the nucleosides were in agreement with the experimental ratios indicating that 6-aza T was successfully incorporated using conventional phosphoramidite chemistry (data not shown).
Hybridization of oligonucleotides
The melting temperatures (Tm) for duplexes of ODNs with complementary RNA or DNA are listed in Table 2 for several modified sequences (19) . Table 2 also lists AT m per substitution averaged over the sequences listed.
Modification of the 6-position of thymidine with an isosteric ring nitrogen atom or the more bulky methyl group destabilized the duplex formed with RNA or DNA complement. Destabilization was greater for 5, 6-DiMe dU than for 6-aza T. The 6-aza dC modification exhibited destabilizations somewhat greater than those for 6-aza T.
Substitution of the 5-Me group of T with a halogen (23-25) has essentially no effect on duplex stability In contrast, removal of the 5-Me group of T (dU, 26) destabilizes the duplex slightly. Addition of a 5-Me or 5-Br group to dC (27, 28) , increases duplex T m 0.5 to 1.2°C per substitution. Other investigators have reported similar results with 5-Me pyrimidines (20) .
'H NMR (NOE) experiments and molecular modeling results demonstrate 6-Me dU and 5,6-DiMe dU adopt the synconformation (21); the a/iri-conformation is prevented due to steric bulk of the 6-methyl group. Our hybridization results are consistent with such a structure for 6-Me dU and 5,6-DiMe dU containing ODNs. Duplex destabilization caused by these modifications may be due to inability of 6-methyl pyrimidines to adopt the anri-conforrnation in the modified ODNs required for appropriate Watson-Crick hydrogen bonding in an A-or B-form duplex.
Nucleolytic degradation
ODNs containing a 3'-terminal cap comprised of one to three T or C modified nucleosides (6-aza T, 6-aza dC, 5-Br dU, 5,6-DiMe dU, and 6-Me dU, Table 3 ) were examined for nuclease sensitivity in DMEM media supplemented with 10% heat inactivated (55 °C for 30 min) FCS. The predominant nucleolytic degradation in sera systems of this nature has been established to be 3' to 5'-exonuclease (22) . A variety of 3' capping strategies and phosphate-backbone modifications, which prevent degradation by serum nucleases, have been reported (23) .
The results of the nuclease stability experiments are summarized in Table 3 . The control ODN A containing three unmodified thymidines at the n-1, n-2 and n-3 positions was rapidly degraded with an approximate half life of 0.5 h for hydrolysis of the first nucleotide from the 3'-end of the ODN. Introduction of 6-aza T at the n-1, n-2 and n-3 positions (ODN B) increased the half life of the n-2 oligomer (cleavage of n-1 to n-2) ~7-fold (3.5 vs. 0.5 h) over control ODN A. Introduction of a methyl group in die 6-position of T (5,6-DiMe dU) and incorporation at two or three sites (ODN K and L) provided a 48-and ~ 10-fold increase in half-life vs. control ODN A. A cap of diree 6-aza Ts at the n, n-1, and n-2 positions (ODN D) afforded roughly 12-fold increase in half-life (3.7 vs. 0.3 h) over control ODN C. One or two 6-aza T modifications at me 3'-end provided about 3 and 7-fold increases in half-lives (ODN F and E) compared to control ODN C. Three 6-Aza C at the n-1, n-2 and n-3 positions (ODN H) provides about 10-fold increase in half life of n-2 (10 vs. 1 h) over control ODN G. A 5-Br dU capped oligomer J was only twice as stable as the control ODN I in FCS.
The structural identity of ODNs containing 6-aza T was confirmed by HPLC analysis of the enzymatic degradation of [5'-d(AAA TAG TGT TGC TGA TCT TGA C)]. HPLC analysis after incubation at 37 °C for 63 h exhibited four nucleosides, corresponding to dC, dG, 6-aza T and dA. The unmodified control sequence was completely converted to dC, dG, T, and dA within 0.5 h. Incubation of the oligomer for up to 14 h was insufficient to complete the digestion. At these shorter incubation times, peaks other than the expected nucleosides were observed. As die incubation time increased, these peaks diminished and the 6-aza T peak increased. These results suggest that incorporation of 6-aza T nucleosides impart substantial nuclease resistance to the modified ODN.
Ribonuclease H activity
Since the mechanism of action of antisense oligonucleotides is most often considered to be cleavage of targeted mRNA by RNase H (2), we were interested in determining if ODNs containing heterocylic modification in the pyrimidine ring would support this activity. This led us to incorporate 6-aza T or 5-Br dU into an antisense ODN to human 5-lipoxygenase DNA [(5'-d(AAA TAG TGT TGC TGA TCT TGA Q wherein T indicates 6-aza T or 5-Br dU] and determine whether die modified ODNscomplemenlary RNA duplexes were substrates for RNase H. The (8) average AT^mod. 6AzadC (13) average AT m /mod. 6-MedU (17) average ATn/mod. 5,6-DiMe dU (22) average AT m /mod. 5-1 dU (23) average AT^mod. 5-Br dU (24) average AT^mod. 5-FdU (25) average ATn/mod. dU
average ATn/mod. 5-Br dC (27) average ATJmod. E.coli RNase H requires at least 2 sequential ribonucleotides paired with two ribodeoxynucleotides within a duplex to cleave in the ribonucleotide portion (4) and mammalian RNase H (HeLa cells) may require at least a five base pair duplex (11) . The modified ODNs sequence studied, has eight 6-aza T or 5-Br dU modifications, separated by no more than two natural bases, and should support cleavage by E.coli RNase H but may not support RNase H from HeLa cell extracts. Our results indicated that E. coli RNase H was able to recognize and cleave mRNA bound to either natural or 6-aza T modified DNA (data not shown). Similar cleavage results were found when the 5-Br dU modified DNA-RNA complement was treated with HeLa cell extracts.
CONCLUSIONS
Our primary objective in this work was to examine if the 5 and 6-positions of the pyrimidine ring coul<3 be used to modulate the essential antisense properties of ODNs. One must consider that any structural perturbation of the pyrimidines devised to obtain nuclease resistance must be compatible with an appropriate level of specificity and binding affinity to the targeted RNA to provide useful antisense activity. Would the pyrimidine modified ODNs support RNase H mediated cleavage of the targeted RNA is another design feature to consider? 3'-Capping of an ODN with 6-aza T or 6-aza dC enhanced nuclease resistance compared to the unmodified sequence (7-to 12-fold for caps of three substituted pyrimidines); even greater nuclease resistance was obtained by placing a methyl group in the 6-position of T (48-fold increase for ODN K). However, these data are not sufficient to allow us to conclude that FCS exonuclease recognition of single-stranded DNA is through the 6-position of pyrimidines and requires further studies.
The 6-aza modified ODNs, in addition to their enhanced nuclease resistance, demonstrate reasonable binding affinities (destabilization of only -1.4 to -1.8°C/modification). This level of destabilization is in the range of methoxyethylamidates (31) and methylphosphonates (32) , which also provide enhanced nuclease stability to antisense ODNs. Furthermore, we find that the pyrimidine modified oligonucleotides form heteroduplexes with RNA that support RNase H cleavage. Our data demonstrated that a ring nitrogen in the 6-position of T or a bromo group in the 5-position of dU provided modified ODNs that support RNase H cleavage.Oligonucleotides with backbone modifications such as methylphosphonates and amidates or with sugar modifications such as 2'-Omethyls or a-sugars do not form heteroduplexes that support RNase H activity (2) . These types of modified ODNs may form heteroduplexs that do not allow conformations necessary for the formation of the enzyme-substrate complex. Further studies are in progress to understand the interactions of pyrimidines with cellular nucleases.
EXPERIMENTAL
The 'H NMR spectra were recorded on a Varian 400 MHz instrument. Chemical shifts were reported (6 ppm) relative to DMSO or TMS. The 31 P NMR spectra were recorded on a Varian 400 MHz instrument at 161.9 MHz. Chemical shifts were reported relative to H 3 PO 4 used as external standard. Thin-layer chromatography (tic) was performed on Merk precoated silica gel 6OF254 plates. Silica gel (ICN 32/63;/60 A) was used for flash chromatography. All solvents used were sure-seal (Aldrich Co.) reagent grade. Evaporation's were conducted under diminished pressure with the bath temperature below 30°C.
Abbreviations: 6-aza T: 6-azathymidine; 6-aza dC: 6-aza-2'deoxycytidine; 6-Me dU: 6-methyl-2'-deoxyuridine; 5, 6-DiMe dU: 5,6-dimethyl-2'-deoxyuridine; 5-1 dU: 5-iodo-2'deoxyuridine; 5-Br dU: 5-bromo-2'-deoxyuridine; 5-F dU: 5-fluoro-2'-deoxyuridine; 5-Br dU: 5-bromo-2'-deoxcytidine; 5-Me dC: 5-methyl-2'-deoxycytidine; DMTC1: 4,4'-dimethoxytriphenylmethyl chloride; Cul: copper iodide; NaOMe: sodium methoxide; DIPEA: N,N-diisopropyl ethylamine; THF: tetrahydrofuran; DPPC: N, N-diisopropylmethylphosphonamidic chloride; HMDS: 1,1,1,3,3,3-hexamethyldisilazane; TMSC1: chlorotrimethylsilane; RT: room temperature; CC: column chromatography; DMAP: 4-dimethylaminopyridine; EDTA: ethylenediaminetetraacetic acid; DMEM: Dulbecco's modified essential medium; FCS: 10% fetal calf serum.
General methods for (i) silylation/glycosylation, (ii) detoluoylation, (iii) tritylation, (iv) phosphoramidation
Method (i) Silylation/glycosylation (e.g., 1 -4, and 18-19) (2-5: a representative example). A mixture of 6-azathymine (Aldrich Co.)(5.0 g, 39.4 mmol), HMDS (15 ml), and TMSC1 (0.5 ml) was heated to reflux (150°C) for 1 h. The excess of HMDS/TMSC1 was removed under vacuum. The residual oil crystallized on drying under vacuum to furnish 6.57 g (61%) of 2; mp 43°C. A mixture of 2 (4.0 g, 14.7 mmol) and 3 (4.8 g, 12.4 mmol) in dry CHC1 3 (300 ml) was stirred at RT under Argon. Cul (2.4 g, 12.4 mmol) was added to the solution and slurry stirred for 3 h at RT. The reaction was quenched by addition of sat. aq. NaHCO 3 (200 ml), stirred for 15 min and filtered through a pad of celite. The CHC1 3 layer was separated, washed (sat. NaCl, 200 ml), dried (MgS0 4 ) and concentrated. The residue was purified by short silica gel CC. Elution with EtOAc/hexanes (1:1, v/v) furnished the product, which on crystallization gave 4.37 g (in two crops, 75.6%) of analytically pure 5, mp 170°C [lit. (24) 173-175°C].
Method (ii) Detoluoylation (e.g., 9-10, 19-20) (5-6: a representative example). To a stirred solution of 5 (0.48 g, 1 mmol) in MeOH (15 ml) was added NaOMe (50 mg) at RT. After 1 h, the solution was neutralized (Dowex-50H + ) and filtered. The resin was washed with MeOH (2x25 ml). The combined filtrates were concentrated under vacuum and the residue dissolved in water (3 ml), washed with CHC1 3 (3x5 ml). The aq. layer was freeze dried to yield 6; 0.23 g (96%)(compound 6 was identical in all respects e.g. UV, 'H NMR and tic to the values in reference 24). (e.g., 10-11,15-16, 20-21) (6-7: a representative example). To a stirred solution of 6 (2.43 g,10 mmol) in dry pyridine (100 ml) was added DMTC1 (4.06 g, 12 mmol) and DMAP (0.12 g, 1 mmol) at RT. The solution was stirred for 6 h and reaction quenched by adding MeOH (10 ml). The reaction mixture was concentrated under vacuum and the residue dissolved in CH 2 C1 2 (200 ml), washed (sat. NaHCCb , 100 ml and sat. NaCl, 100 ml) and dried (MgSO 4 ). The solution was concentrated under vacuum and the residue purified by silica gel CC (pre wet with EtOAc/TEA, 99:1, v/v, until basic and eluted with same solvent). Appropriate fractions were pooled and evaporated to furnish 3.82 g (70%) of 7 as white foam. Homogenous by tic (CHCl 3 /MeOH, 9:1, v/v) R f = 0.46. (e.g., 12-13,16-17, 21-22 ) (7-8: A representative example). To a stirred solution of 7 (1.63 g, 3 mmol) in dry THF (50 ml) was added DIPEA (1.56 ml, 9 mmol) and solution cooled to 0°C. DPPC (1.42 ml, 6 mmol) was added to the cold solution over a period of 15 min. The reaction mixture was then stirred at RT for 2 h. EtOAc (100 ml, containing 1 % TEA) was added and the solution washed (sat. NaCl, 2x 100 ml), dried (MgSO 4 ) and solvent removed under reduced pressure. The residue was purified by silica gel CC (same as in method iii). Pooling and concentration of appropriate fractions furnished 1.41 g (66%) of 8 as white foam. Homogenous by tic (CHCyMeOH, 9:1,v/v) R f = 0.65. (20) . Silylation of 5,6-dimethyluracil (25)(5 g, 35.71 mmol) followed by glycosylation with 3 (13.96 g, 36 mmol) as described in method (i) furnished a mixture of N-\ and N-2 (7:3 respectively by 'H NMR) glycosylated products in 50% yield. The desired compound 19 was easily separated from minor positional isomer by silica gel CC. The N-l nucleoside 19 was deblocked by method (ii) in quantitative yield to furnish 20; mp 170-171°C.
Method (iii) Tritylation
Method (iv) Phosphoramidation
5,6-Dimethyl-2'-deoxyuridine
ODN synthesis. All ODNs were synthesized on an ABI model 380 B DNA synthesizer using standard chemistry (17) . The 6-aza T was coupled to a controlled-pore glass (LCAA-CPG) via a recently reported method (18) . The 6-aza T attached CPG served as the starting material for introducing the modification at the 3'-end of an ODN.
Determination of thermal stability
Absorbance vs. temperature curves were measured at 260 nm using a Gilford 260 spectrophotometer interfaced to an IBM PC computer and a Gilford Response II spectrophotometer. The buffer contained 100 mM Na + , 10 mM phosphate and 0.1 mM EDTA, pH 7.0. Oligonucleotide concentration was 4 mM each strand determined from the absorbance at 85 °C and extinction coefficients calculated according to Puglisi and Tinoco (26) . T m 's of duplex formation were obtained from fits of data to a two state model with linear sloping baselines (27) . Reported parameters are averages of at least three experiments.
Enzymatic digestion of oligonucleotides
ODNs (66 mg/ml, ~ 13 mM) were incubated at 37°C in DMEM supplemented with 10% heat inactivated (55 °C for 1 h) FCS for 24 h. At various time points 15 /J of the ODN/media + FCS mixture were removed and added to-20 /J of 9 M urea in 2XTBE (178 mM Tris, 178 mM borate and 4 mM EDTA, pH 8.0), mixed and stored at -20°C. The samples were then analyzed by poly aery lamide electrophoresis (20% PA/7 M urea denaturing gels) and visualized by stains all reagent (l-ethyl-2-[3-(l-ethylnapthof 1,2-<f|thiazolin-2-ylidene)-2-methylpropenyl]napthol [l,2-<flthiazolium bromide). Following electrophoresis and staining, degradation products were quantitated using laser densitometry (Molecular Dynamics Densitometer, Molecular Dynamics, Sunnyvale, CA). Rates of degradation were determined for the loss of the first 6-aza T from the 3'-end of the ODN (see ref. 28 for experimental details). The data was graphed and the graphic estimations for the half-life of the modified ODNs were made by comparison to the unmodified ODN A.
Modified oligonucleotide compositional analysis
Enzymatic degradation was carried out using 0.1 units of snake venom phosphodiesterase (Pharmacia, Piscataway, NJ), 23 units nuclease PI (Gibco BRL, Gaithersburg, MD), 24 units calf intestinal phosphatase (Boehringer Mannheim, Indianapolis, IN), and 10 nanomoles oligomer in 50 mM Tris-HCl pH 8.5, 14 mM MgCl 2 , and 72 mM NaCl in a total volume of 20 /*1. Reactions were incubated at 37°C for 30 min. HPLC analysis was carried out using a reverse phase column (Alltech nucleoside/nucleotide; 4.6x250 mm; Alltech Associates, Inc., Deerfield, IL). All analyses were performed at room temperature. The solvents used were A: water and B: acetonitrile. Separation of 6-aza T from other nucleosides was accomplished with the following gradient: 0-5 minutes, 2% B (isocratic); 5-20 minutes, 2% B to 10% B (linear); 20-40 minutes, 10% B to 50% B. The integrated area per nanomole was determined using a nucleoside standards. Relative nucleoside ratios were calculated by converting integrated areas to molar values and comparing all values to thymidine, which was set at its expected value for each oligomer.
RNase H mediated cleavage E.coli RNase H cleavage:
The 5-lipoxygenase mRNA (2.5 Kb) was synthesized in vitro for this experiment. 2.5 /tg mRNA (3.2 pM) was suspended in 10 id 10 mM Tris-HQ, pH 7.8, and heated to 60°C for 5 min and then rapidly cooled to 4°C on ice. A 3-fold molar excess of oligonucleotide [5' d(AAA TAGTGT  TGC TGA TCT TGA Q] , where T is 6-aza T (9.6 pM) was added and the solution adjusted to 3 mM MgCl 2 , 0.5 mM ATP, and 20 mM creatine phosphate, final volume 20 /tl. Mixtures were incubated at 37°C for 10 min and then 0.8 Units E.coli RNase H was added and the reaction allowed to continue for 15 min at 37°C. The samples were then heated to 90°C for 10 min in the presence of formamide gel loading buffer. These samples were analyzed for cleavage using 1.2% agaroseformaldehyde gel electrophoresis. Mammalian RNAse H cleavage: Modified DNA [5'd(AAA TAGTGT TGC TGA TCT TGA C)], where T is 5-Br dU] and complementary synthetic RNA was used to assess in vitro cleavage by HeLa RNase H (29) . The synthetic RNA was end labeled using gamma [^P] ATP and gel purified. The oligo DNA and labeled RNA were then prehybridized at 37 °C for 15 min. and slow cooled to room temperature in 20mM Tris-Cl pH 7.5, lOOmM KC1, lOmM MgCl 2 , lmg/ml tRNA (BRL cat# 5401SA), 40U/reaction RNasin (Promega cat# N251B) at lnM RNA: lOnM DNA. Purified HeLa nuclear extract (30) at 2/xg total protein was then added to the duplexed reactions and incubated at 37°C for 10 min. The reactions were quenched in 2 XTBE/9M urea then loaded directly onto 20% PAG/7M urea.
